
1. plos pathog. 2011 oct;7(10):e1002331. doi: 10.1371/journal.ppat.1002331. epub
2011 oct 27.

the sars-coronavirus-host interactome: identification cyclophilins target
for pan-coronavirus inhibitors.

pfefferle s(1), schöpf j, kögl m, friedel cc, müller ma, carbajo-lozoya j,
stellberger t, von dall'armi e, herzog p, kallies s, niemeyer d, ditt v, kuri t, 
züst r, pumpor k, hilgenfeld r, schwarz f, zimmer r, steffen i, weber f, thiel v,
herrler g, thiel hj, schwegmann-wessels c, pöhlmann s, haas j, drosten c, von
brunn a.

author information: 
(1)bernhard-nocht-institute, hamburg, germany.

coronaviruses (covs) important human animal pathogens induce fatal
respiratory, gastrointestinal neurological disease. outbreak the
severe acute respiratory syndrome (sars) 2002/2003 demonstrated human
vulnerability (coronavirus) cov epidemics. neither vaccines therapeutics
are available human animal covs. knowledge host cell proteins that
take part pivotal virus-host interactions could define broad-spectrum
antiviral targets. study, used systems biology approach employing 
genome-wide yeast-two hybrid interaction screen identify immunopilins (ppia,
ppib, ppih, ppig, fkbp1a, fkbp1b) interaction partners cov
non-structural protein 1 (nsp1). molecules modulate calcineurin/nfat
pathway plays important role immune cell activation. overexpression of
nsp1 infection live sars-cov strongly increased signalling the
calcineurin/nfat pathway enhanced induction interleukin 2, compatible 
with late-stage immunopathogenicity long-term cytokine dysregulation as
observed severe sars cases. conversely, inhibition cyclophilins by
cyclosporine (cspa) blocked replication covs genera, including
sars-cov, human cov-229e -nl-63, feline cov, well avian infectious
bronchitis virus. non-immunosuppressive derivatives cspa might serve as
broad-range cov inhibitors applicable emerging covs well ubiquitous
pathogens humans livestock.

doi: 10.1371/journal.ppat.1002331 
pmcid: pmc3203193
pmid: 22046132  [indexed medline]

